GANNON STEVEN Insider Trades

Insider Trading History

Track insider trading activity for GANNON STEVEN. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $707k 10,507 shares
Last Trade
Jun 03, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$647k 12,100 shares
$53.46
$67.30
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $0 0 shares
Last Trade
Jun 01, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$141k 2,645 shares
$53.41
$67.30
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $894k 13,286 shares
Last Trade
Jun 01, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$141k 2,645 shares
$53.41
$67.30
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $799k 11,870 shares
Last Trade
Jun 01, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$75.6k 1,416 shares
$53.41
$67.30
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $716k 10,641 shares
Last Trade
May 12, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$193k 3,500 shares
$55.00
$67.30
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $0 0 shares
Last Trade
May 12, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$193k 3,500 shares
$55.00
$67.30
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $481k 7,141 shares
Last Trade
Jun 05, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$91.4 3 shares
$30.48
$67.30
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $1.14M 17,012 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$523k 17,012 shares
$30.73
$67.30
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $481k 7,144 shares
Last Trade
May 14, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$153k 5,144 shares
$29.74
$67.30
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $0 0 shares
Last Trade
May 14, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$153k 5,144 shares
$29.74
$67.30
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $1.05M 15,542 shares
Last Trade
Jun 05, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$593k 15,542 shares
$38.16
$67.30
Fusion Pharmaceuticals
Fusion Pharmaceuticals FUSN
Director
Holding Value $0 0 shares
Last Trade
Jun 04, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$5.27M 244,411 shares
$21.55
$21.55
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $942k 14,000 shares
Last Trade
Mar 07, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$278k 6,000 shares
$46.28
$67.30
Fusion Pharmaceuticals
Fusion Pharmaceuticals FUSN
Director
Holding Value $366k 17,000 shares
Last Trade
Jun 14, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$78.9k 17,000 shares
$4.64
$21.55
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $1.24M 18,475 shares
Last Trade
Jun 02, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$720k 18,475 shares
$38.96
$67.30
Fusion Pharmaceuticals
Fusion Pharmaceuticals FUSN
Director
Holding Value $1.22M 56,400 shares
Last Trade
Aug 11, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$90.1k 44,400 shares
$2.03
$21.55
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $1.21M 18,000 shares
Last Trade
Jun 28, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$542k 18,000 shares
$30.11
$67.30
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $1.21M 18,000 shares
Last Trade
Jun 28, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$542k 18,000 shares
$30.11
$67.30
Fusion Pharmaceuticals
Fusion Pharmaceuticals FUSN
Director
Holding Value $366k 17,000 shares
Last Trade
Jun 14, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$61.2k 17,000 shares
$3.60
$21.55
Fusion Pharmaceuticals
Fusion Pharmaceuticals FUSN
Director
Holding Value $259k 12,000 shares
Last Trade
Aug 23, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$22.6k 2,829 shares
$7.99
$21.55

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up